Pesticides; tolerances in food, animal feeds, and raw agricultural commodities: Tribenuron methyl,

[Federal Register: September 22, 2004 (Volume 69, Number 183)]

[Rules and Regulations]

[Page 56711-56718]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr22se04-15]

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[OPP-2004-0278; FRL-7679-5]

Tribenuron Methyl; Pesticide Tolerance

AGENCY: Environmental Protection Agency EPA).

ACTION: Final rule.

SUMMARY: This regulation establishes a tolerance for residues of tribenuron methyl in or on canola, seed; cotton, gin byproducts; cotton, undelinted seed; and flax, seed. E.I. DuPont De Nemours and Company requested this tolerance under the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food Quality Protection Act of 1996 (FQPA). In addition, this regulatory action is part of the tolerance reassessment requirements of section 408(q) of the FFDCA 21 U.S.C. 346a(q), as amended by the FQPA of 1996. By law, EPA is required to reassess 100% of the tolerances in existence on August 2, 1996, by August 2006. This regulatory action will count for eight reassessments toward the August 2006 deadline.

DATES: This regulation is effective September 22, 2004. Objections and requests for hearings must be received on or before November 22, 2004.

ADDRESSES: To submit a written objection or hearing request follow the detailed instructions as provided in Unit VI. of the SUPPLEMENTARY INFORMATION. EPA has established a docket for this action under Docket identification (ID) number OPP-2004-0278. All documents in the docket are listed in the EDOCKET index at http://www.epa.gov/edocket. Although

listed in the index, some information is not publicly available, i.e., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the Internet and will be publicly available only in hard copy form. Publicly available docket materials are available either electronically in EDOCKET or in hard copy at the Public Information and Records Integrity Branch (PIRIB), Rm. 119, Crystal Mall 2, 1801 S. Bell St., Arlington, VA. This docket facility is open from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The docket telephone number is (703) 305-5805.

FOR FURTHER INFORMATION CONTACT: James Tompkins, Registration Division (7505C), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,Washington, DC 20460-0001; telephone number: 703-305-5697 e-mail address: tompkins.jim@epa.gov.

SUPPLEMENTARY INFORMATION:

  1. General Information

    1. Does This Action Apply to Me?

      You may be potentially affected by this action if you are an agricultural producer, food manufacturer, or pesticide manufacturer. Potentially affected entities may include, but are not limited to:

      Crop production (NAICS 111), e.g., agricultural workers; greenhouse, nursery, and floriculture workers; farmers.

      Animal production (NAICS 112), e.g., cattle ranchers and farmers, dairy cattle farmers, livestock farmers.

      Food manufacturing (NAICS 311), e.g., agricultural workers; farmers; greenhouse, nursery, and floriculture workers; ranchers; pesticide applicators.

      Pesticide manufacturing (NAICS 32532), e.g., agricultural workers; commercial applicators; farmers; greenhouse, nursery, and floriculture workers; residential users.

      This listing is not intended to be exhaustive, but rather provides a guide for readers regarding entities likely to be affected by this action. Other types of entities not listed in this unit could also be affected. The North American Industrial Classification System (NAICS) codes have been provided to assist you and others in determining whether this action might apply to certain entities. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT.

    2. How Can I Access Electronic Copies of This Document and Other Related Information?

      In addition to using EDOCKET (http://www.epa.gov/edocket/), you may

      access this Federal Register document electronically through the EPA Internet under the ``Federal Register'' listings at http://www.epa.gov/fedrgstr/. A frequently updated electronic version of 40 CFR part 180

      is available at E-CFR Beta Site Two at http://www.gpoaccess.gov/ecfr/.

      To access the OPPTS Harmonized Guidelines referenced in this document, go directly to the guidelines at http://www.epa.gpo/opptsfrs/home/guidelin.htm/ .

  2. Background and Statutory Findings

    In the Federal Register of July 7, 2004 (69 FR 40909) (FRL-7364-8), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21 U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP 0F6135) by E.I. DuPont de Nemours and Company, DuPont Crop Protection, Barley Mill Plaza, Wilmington, DE 19880-0038. The petition requested that 40 CFR 180.451 be amended by establishing a tolerance for residues of the herbicide tribenuron methyl, [methyl 2-[[[[(4-methoxy -6-methyl-1, 3, 5-triazin-2-yl) methylamino] carbobyl]amino]sulfonyl]benzoate], in or on imazethapyr tolerant canola at 0.02 parts per million (ppm), cotton gin trash at 0.02 ppm, cotton seed at 0.02 ppm, and Crop Development Center (CDC) triffid flax at 0.02 ppm. That notice included a summary of the petition prepared by E. I. DuPont de Nemours and Company, the registrant. There were no comments received in response to the notice of filing.

    During the course of the review the Agency decided to correct the Company address and correct the listings for the commodities canola, cotton and flax. The company address is changed to DuPont Crop Protection, Stine-Haskell Research Center, Newark, DE 19714. The listing of the commodities imazethapyr tolerant canola, cotton seed, cotton gin trash and Crop Development Center (CDC) triffid flax are corrected to read canola, seed; cotton, undelinted seed; cotton, gin byproducts and flax, seed; respectively.

    Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a tolerance (the legal limit for a pesticide chemical residue in or on a food) only if EPA determines that the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a reasonable certainty that no harm will result from aggregate exposure to the pesticide chemical residue, including all anticipated dietary exposures and all other exposures for which there is reliable information.'' This includes exposure through drinking water and in residential settings, but does not include occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to give special consideration to exposure of infants and children to the pesticide chemical residue in establishing a tolerance and to ``ensure that there is a reasonable certainty that no harm will result to infants and children from aggregate exposure to the pesticide chemical residue. * * *''

    EPA performs a number of analyses to determine the risks from aggregate

    [[Page 56712]]

    exposure to pesticide residues. For further discussion of the regulatory requirements of section 408 of FFDCA and a complete description of the risk assessment process, see the final rule on Bifenthrin Pesticide Tolerances (62 FR 62961, November 26, 1997) (FRL- 5754-7).

  3. Aggregate Risk Assessment and Determination of Safety

    Consistent with section 408(b)(2)(D) of FFDCA, EPA has reviewed the available scientific data and other relevant information in support of this action. EPA has sufficient data to assess the hazards of and to make a determination on aggregate exposure, consistent with section 408(b)(2) of FFDCA, for a tolerance for residues of tribenuron methyl on canola, seed at 0.02 ppm, cotton, gin byproducts at 0.02 ppm, cotton, undelinted seed at 0.02 ppm, and flax, seed at 0.02 ppm. EPA's assessment of exposures and risks associated with establishing the tolerance follows.

    1. Toxicological Profile

      EPA has evaluated the available toxicity data and considered its validity, completeness, and reliability as well as the relationship of the results of the studies to human risk. EPA has also considered available information concerning the variability of the sensitivities of major identifiable subgroups of consumers, including infants and children. The nature of the toxic effects caused by tribenuron methyl are discussed in Table 1 of this unit as well as the no-observed- adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect- level (LOAEL) from the toxicity studies reviewed.

      Table 1.--Subchronic, Chronic, and Other Toxicity

      Guideline No.

      Study Type

      Results

      870.3100

      90-Day oral toxicity-- NOAEL = 7 (males and 8 (females) milligrams/ rodents

      kilogram/day (mg/kg/day) LOAEL = 118 (males) and 135 (females) mg/kg/ day based on decreased body weight gain, food consumption and food efficiency; decreased absolute heart, liver, and kidney weights; increase relative brain, heart, liver, kidney, testes, and spleen weights; decreased serum glucose and globulin; no histopathologic lesions; likely cachexia

      870.3150

      90-Day oral toxicity-- NOAEL = > 73.3 (males) and > 78.0 (females) nonrodents

      HDT mg/kg/day

      870.3200

      21/28-Day dermal toxicity NOAEL = limit dose, 1,000 mg/kg/day, resulted in serious toxicity and death. No NOAEL or LOEAL defined. Toxicity included treatment site lesions, hypokinesia, decreased body weights and food consumption, and kidney pathology, but the cause of death could not be determined. Although this study is core supplementary, another study is not needed. Worker exposure is expected to be 4 to 5 orders of magnitude less than limit dose.

      870.3700

      Prenatal developmental-- Maternal NOAEL = 20 mg/kg/day rodents

      Maternal LOAEL = 125 mg/kg/day based on decreased maternal body weight gain and food consumption Developmental NOAEL = 20 mg/kg/day Developmental LOAEL = 125 mg/kg/day based on decreased body weight. At 500 mg/kg/day (HDT) there were increased resorption, fetal deaths, and incomplete ossifications

      870.3700

      Prenatal developmental-- Maternal NOAEL = 20 mg/kg/day nonrodents

      Maternal LOAEL = 80 (HDT) mg/kg/day based on 10% decreased food consumption, increased abortions Developmental NOAEL = 20 mg/kg/day Developmental LOAEL = 80 mg/kg/day based on HDT-10% decrease in body weight compared to controls-not statistically significant). Abortions were increased at 80 mg/kg/day. Teratology was not observed.

      870.3800

      Reproduction and fertility Parental/Systemic NOAEL = 2 mg/kg/day effects

      Parental/Systemic LOAEL = 21 mg/kg/day based on decreased body weight gain in F1a adult females Reproductive NOAEL = 2.5 mg/kg/day Reproductive LOAEL = 25 mg/kg/day based on decreased body weight gain during lactation for F1b and F2b pups Offspring NOAEL = 2.5 mg/kg/day Offspring LOAEL = 25 mg/kg/day based on decreased absolute splenic weights

      870.4100

      Chronic toxicity--rodents NOAEL = 0.95 (males)/1.2 (females) mg/kg/ day LOAEL = 10 (males)/13 (females) mg/kg/day based on decreased body weight gain in both sexes. Statistically significant increase in mammary gland adenocarcinomas in female rats at 76 mg/kg/day highest dose tested (HDT)

      870.4100

      Chronic toxicity--dogs NOAEL = 0.79 (males)/8.16 (females) mg/kg/ day LOAEL = 8.18 (males)/52.02 (females) mg/kg/ day based on elevated serum bilirubin, AST, and urinary volume, reduced body weight gain (20%) in females; increased serum creatinine, bilirubin, AST, and globulin, decreased body weight gain of 18.2% in males.

      [[Page 56713]]

      870.4200

      Carcinogenicity--rats NOAEL = 0.95 (males)/1.2 (females) mg/kg/ day LOAEL = 10 (males)/13 (females) mg/kg/day based on decreased body weight gain in both sexes. Statistically significant increase in mammary gland adenocarcinomas in female rats at 76 mg/kg/day (HDT)

      870.4300

      Supplement-Estrogenic Dose levels: 0 and 390 mg/kg/day for 90 Activity in Rats

      days. Weak estrogenic activity was observed in female rats. The technical and seven metabolites may be agonists for the estrogen receptor.

      870.4300

      Carcinogenicity--mice NOAEL = 3 (males) mg/kg/day LOAEL = 30 mg/kg/day based on bilateral seminiferous degenertion and oligospermia. Although frank toxicity was not observed in the females, HED peer review judged the dose levels to be adequate. No evidence of carcinogenicity

      870.5100

      Gene mutation Bacterial negative in Salmonella Typhimurium

      870.5300

      Gene Mutation Mammalian negative in Chinese hamster ovary cells in in vitro

      870.5375

      Cytogenetics

      negative for structural chromosomal damage and when tested in a micronucleus test in mice

      870.7485

      Metabolism and

      The major route of excretion in rats is the pharmacokinetics

      urine. Urine samples contained two to four times of the administered radioactivity than the feces. Tissue levels of tribenuron methyl and its metabolites increased with dose, but there was no concentration of radioactivity in any particular organ or tissue.

    2. Toxicological Endpoints

      The dose at which no adverse effects are observed (the NOAEL) from the toxicology study identified as appropriate for use in risk assessment is used to estimate the toxicological level of concern (LOC). However, the lowest dose at which adverse effects of concern are identified (the LOAEL) is sometimes used for risk assessment if no NOAEL was achieved in the toxicology study selected. An uncertainty factor (UF) is applied to reflect uncertainties inherent in the extrapolation from laboratory animal data to humans and in the variations in sensitivity among members of the human population as well as other unknowns. An UF of 100 is routinely used, 10X to account for interspecies differences and 10X for intraspecies differences.

      Three other types of safety or uncertainty factors may be used: ``Traditional uncertainty factors;'' the ``special FQPA safety factor;'' and the ``default FQPA safety factor.'' By the term ``traditional uncertainty factor,'' EPA is referring to those additional uncertainty factors used prior to FQPA passage to account for database deficiencies. These traditional uncertainty factors have been incorporated by the FQPA into the additional safety factor for the protection of infants and children. The term ``special FQPA safety factor'' refers to those safety factors that are deemed necessary for the protection of infants and children primarily as a result of the FQPA. The ``default FQPA safety factor'' is the additional 10X safety factor that is mandated by the statute unless it is decided that there are reliable data to choose a different additional factor (potentially a traditional uncertainty factor or a special FQPA safety factor).

      For dietary risk assessment (other than cancer) the Agency uses the UF to calculate an acute or chronic reference dose (aRfD or cRfD) where the RfD is equal to the NOAEL divided by an UF of 100 to account for interspecies and intraspecies differences and any traditional uncertainty factors deemed appropriate (RfD = NOAEL/UF). Where a special FQPA safety factor or the default FQPA safety factor is used, this additional factor is applied to the RfD by dividing the RfD by such additional factor. The acute or chronic Population Adjusted Dose (aPAD or cPAD) is a modification of the RfD to accommodate this type of safety factor.

      For non-dietary risk assessments (other than cancer) the UF is used to determine the LOC. For example, when 100 is the appropriate UF (10X to account for interspecies differences and 10X for intraspecies differences) the LOC is 100. To estimate risk, a ratio of the NOAEL to exposures (margin of exposure (MOE) = NOAEL/exposure) is calculated and compared to the LOC.

      The linear default risk methodology (Q*) is the primary method currently used by the Agency to quantify carcinogenic risk. The Q* approach assumes that any amount of exposure will lead to some degree of cancer risk. A Q* is calculated and used to estimate risk which represents a probability of occurrence of additional cancer cases (e.g., risk). An example of how such a probability risk is expressed would be to describe the risk as one in one hundred thousand (1 X 10-\5\), one in a million (1 X 10-\6\), or 1 in 10 million (1 X 10-\7\). Under certain specific circumstances, MOE calculations will be used for the carcinogenic risk assessment. In this non-linear approach, a ``point of departure'' is identified below which carcinogenic effects are not expected. The point of departure is typically a NOAEL based on an endpoint related to cancer effects though it may be a different value derived from the dose response curve. To estimate risk, a ratio of the point of departure to exposure (MOEcancer= point of departure/exposures) is calculated.

      A summary of the toxicological endpoints for tribenuron methyl used for human risk assessment is shown in the following Table 2:

      [[Page 56714]]

      Table 2.--Summary of Toxicological Dose and Endpoints for Tribenuron methyl for Use in Human Risk Assessment

      Dose Used in Risk Assessment,

      Special FQPA SF and Exposure Scenario

      Interspecies and Level of Concern for Study and Toxicological Intraspecies and any Risk Assessment

      Effects Traditional UF

      Chronic Dietary (All populations) NOAEL= 0.8 mg/kg/day Special FQPA SF = 1 Chronic Dog LOAEL = 8.2 UF = 100............... cPAD = chronic RfD / mg/kg/day based on Chronic RfD = 0.008 mg/ Special FQPA SF =

      elevated bilirubin, kg/day.

      0.008 mg/kg/day.

      elevated serum liver enzymes, increased urinary volume, and 20% reduction in body weight gain.

      Cancer (oral, dermal, inhalation) Classified as Group C chronic risk assessment NA (possible human

      protective of any carcinogen) not

      potential carcinogenic mutagenic)

      risk

    3. Exposure Assessment

      1. Dietary exposure from food and feed uses. Tolerances have been established (40 CFR 180.451) for the residues of tribenuron methyl, in or on a variety of raw agricultural commodities. Tolerances are established for barley, oats, wheat, and grass forage and hay group. No tolerances for meat products, eggs, or milk are established. Risk assessments were conducted by EPA to assess dietary exposures from tribenuron methyl in food as follows:

        i. Acute exposure. Acute dietary risk assessments are performed for a food-use pesticide, if a toxicological study has indicated the possibility of an effect of concern occurring as a result of a 1-day or single exposure.

        There are no studies that identify an acute hazard based on toxic effects observed following a single oral exposure (dose) of tribenuron methyl. The developmental toxicity rat study in which a 9% reduction in body weight occurred on the fourth day of dosing (day 9) was considered. However, this reduction in body weight gain was only slight and could not be attributed to a single dose since the reduction occurred on day 4 of dosing. Other effects observed in the developmental toxicity study such as decreased fetal wight (7.4%) and increased incidence of fetal resorptions (not statistically significant) were considered for an endpoint in reproductive females, but again, effects could not be attributed to a single dose. Since there was no litter loss or other acute effects, the aRfD is not appropriate for the assessment.

        ii. Chronic exposure. Dietary exposure estimates were conducted using the Lifeline model (Version 2.0) which incorporates consumption data from the USDA Continuing Surveys of Food Intakes by Individuals (CSFII), 1994-96 and 1998. The 1994-96, 1998 data are based on reported consumption of more than 20,000 individuals over two non-consecutive survey days. Foods ``as consumed'' are linked to EPA-defined food commodities using publicly available recipe translation files (developed jointly by USDA/ARS and EPA). Lifeline models individual dietary exposures over a season by selecting a new CSFII diary each day from a set of similar individuals, based on age and season attributes. The Lifeline chronic dietary exposure estimate is based on an average daily exposure from a profile of 1,000 individuals over a 1-year period. Further information regarding the Lifetime model can be found at the following we site:http://www.Lifeline TMgroup.org.

        The following assumptions were made for the chronic exposure assessments: Tolerance level, 100% crop treated (CT), and default processing factors were used. Percent crop treated (PCT) or anticipated residues were not used.

        iii. Cancer. Tribenuron methyl is classified as a Group C (Possible Human Carcinogen). The Agency also concluded that the carcinogenic response observed may be associated with a hormonal imbalance that may not occur at doses below a maximum tolerated dose ( MTD). A quantitative carcinogenic risk assessment for tribenuron methyl is not considered appropriate because: (1) The increased incidence of mammary gland tumors was observed in female rats treated at the dose levels exceeding the (MTD; (2) there was no evidence of genetic toxicity shown in several studies; (3) structural analogs of tribenuron methyl were not associated with carcinogenic responses in rats and mice. In conclusion the Agency considers the chronic risk assessment, making use of the cPAD, to be protective of any potential carcinogenic risk.

      2. Dietary exposure from drinking water. The Agency lacks sufficient monitoring exposure data to complete a comprehensive dietary exposure analysis and risk assessment for tribenuron methyl in drinking water. Because the Agency does not have comprehensive monitoring data, drinking water concentration estimates are made by reliance on simulation or modeling taking into account data on the physical characteristics of tribenuron methyl.

        The Agency uses the FQPA Index Reservoir Screening Tool (FIRST) or the Pesticide Root Zone Model/Exposure Analysis Modeling System (PRZM/ EXAMS), to produce estimates of pesticide concentrations in an index reservoir. The SCI-GROW model is used to predict pesticide concentrations in shallow ground water. For a screening-level assessment for surface water EPA will use FIRST (a tier 1 model) before using PRZM/EXAMS (a tier 2 model). The FIRST model is a subset of the PRZM/EXAMS model that uses a specific high-end runoff scenario for pesticides. Both FIRST and PRZM/EXAMS incorporate an index reservoir environment, and both models include a percent crop area factor as an adjustment to account for the maximum percent crop coverage within a watershed or drainage basin.

        None of these models include consideration of the impact processing (mixing, dilution, or treatment) of raw water for distribution as drinking water would likely have on the removal of pesticides from the source water. The primary use of these models by the Agency at this stage is to provide a screen for sorting out pesticides for which it is unlikely that drinking water concentrations would exceed human health levels of concern.

        Since the models used are considered to be screening tools in the risk assessment process, the Agency does not use estimated environmental concentrations (EECs), which are the model estimates of a pesticide's concentration in water. EECs derived from these models are used to quantify drinking water exposure and risk as a %RfD or %PAD. Instead, drinking water levels of comparison (DWLOCs) are

        [[Page 56715]]

        calculated and used as a point of comparison against the model estimates of a pesticide's concentration in water. DWLOCs are theoretical upper limits on a pesticide's concentration in drinking water in light of total aggregate exposure to a pesticide in food, and from residential uses. Since DWLOCs address total aggregate exposure to tribenuron methyl they are further discussed in the aggregate risk Unit III.E.

        Based on the FIRST, and SCI-GROW models, the EECs of tribenuron methyl for chronic exposures are estimated to be .413 ppb for surface water and 0.000006 ppb for ground water.

      3. From non-dietary exposure. The term ``residential exposure'' is used in this document to refer to non-occupational, non-dietary exposure (e.g., for lawn and garden pest control, indoor pest control, termiticides, and flea and tick control on pets).

        Tribenuron methyl is not registered for use on any sites that would result in residential exposure.

      4. Cumulative effects from substances with a common mechanism of toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when considering whether to establish, modify, or revoke a tolerance, the Agency consider ``available information'' concerning the cumulative effects of a particular pesticide's residues and ``other substances that have a common mechanism of toxicity.''

        Unlike other pesticides for which EPA has followed a cumulative risk approach based on a common mechanism of toxicity, EPA has not made a common mechanism of toxicity finding as to tribenuron methyl and any other substances and tribenuron methyl does not appear to produce a toxic metabolite produced by other substances. For the purposes of this tolerance action, therefore, EPA has not assumed that tribenuron methyl has a common mechanism of toxicity with other substances. For information regarding EPA's efforts to determine which chemicals have a common mechanism of toxicity and to evaluate the cumulative effects of such chemicals, see the policy statements released by EPA's Office of Pesticide Programs (OPP) concerning common mechanism determinations and procedures for cumulating effects from substances found to have a common mechanism on EPA's web site at http://www.epa.gov/pesticides/cumulative/ .

    4. Safety Factor for Infants and Children

      1. In general. Section 408 of FFDCA provides that EPA shall apply an additional 10-fold margin of safety for infants and children in the case of threshold effects to account for prenatal and postnatal toxicity and the completeness of the database on toxicity and exposure unless EPA determines based on reliable data that a different margin of safety will be safe for infants and children. Margins of safety are incorporated into EPA risk assessments either directly through use of a maragin of exposure (MOE) analysis or through using uncertainty (safety) factors in calculating a dose level that poses no appreciable risk to humans. In applying this provision, EPA either retains the default value of 10X when reliable data do not support the choice of a different factor, or, if reliable data are available, EPA uses a different additional safety factor value based on the use of traditional uncertainty factors and/or special FQPA safety factors, as appropriate.

      2. Prenatal and postnatal sensitivity. Developmental and reproductive toxicity studies indicated no increased susceptibility of offspring to tribenuron methyl. However, increased number of resorptions (not statistically significant) and fetal deaths were observed at the highest dose tested when administered during the critical gestation period of pregnancy, in both the rat and the rabbit. The resorptions and fetal deaths indicate an effect due to maternal toxicity. In a two-generation reproduction study, reproductive effects of tribenuron methyl were limited to decreased body weight gain during lactation.

      3. Conclusion. There is a complete toxicity database for tribenuron methyl and exposure data are complete or are estimated based on data that reasonably accounts for potential exposures. The impact of tribenuron methyl on the nervous system has not been specifically evaluated in neurotoxicity studies. However, there was no evidence of neurotoxicity or neuropathology seen in either acute, subchronic, chronic, or reproductive studies, and there are no concerns for potential developmental neurotoxicity. Therefore, neurotoxicity data are not required for tribenuron methyl. EPA determined that the 10X SF to protect infants and children should be removed. The FQPA factor is removed because of the completeness of the toxicity and exposure database and because the available data provided no indication of increased susceptibility (quantitative or qualitative) to rats or rabbits following in utero exposure to tribenuron methyl, or to prenatal and/or postnatal exposure in rat reproduction studies and there are no concerns for potential developmental neurotoxicity.

    5. Aggregate Risks and Determination of Safety

      To estimate total aggregate exposure to a pesticide from food, drinking water, and residential uses, the Agency calculates DWLOCs (drinking water level of concern) which are used as a point of comparison against EECs. DWLOC values are not regulatory standards for drinking water. DWLOCs are theoretical upper limits on a pesticide's concentration in drinking water in light of total aggregate exposure to a pesticide in food and residential uses. In calculating a DWLOC, the Agency determines how much of the acceptable exposure (i.e., the PAD) is available for exposure through drinking water e.g., allowable chronic water exposure (mg/kg/day) = cPAD - (average food + residential exposure). This allowable exposure through drinking water is used to calculate a DWLOC.

      A DWLOC will vary depending on the toxic endpoint, drinking water consumption, and body weights. Default body weights and consumption values as used by the EPA's Office of Water are used to calculate DWLOCs: 2 liter (L)/70 kg (adult male), 2L/60 kg (adult female), and 1L/10 kg (child). Default body weights and drinking water consumption values vary on an individual basis. This variation will be taken into account in more refined screening-level and quantitative drinking water exposure assessments. Different populations will have different DWLOCs. Generally, a DWLOC is calculated for each type of risk assessment used: Acute, short-term, intermediate-term, chronic, and cancer.

      When EECs for surface water and ground water are less than the calculated DWLOCs, OPP concludes with reasonable certainty that exposures to the pesticide in drinking water (when considered along with other sources of exposure for which OPP has reliable data) would not result in unacceptable levels of aggregate human health risk at this time. Because OPP considers the aggregate risk resulting from multiple exposure pathways associated with a pesticide's uses, levels of comparison in drinking water may vary as those uses change. If new uses are added in the future, OPP will reassess the potential impacts of residues of the pesticide in drinking water as a part of the aggregate risk assessment process.

      1. Acute risk. An acute risk assessment was not performed; there were no studies that identify an acute hazard based on toxic effects observed following a single oral exposure (dose) of tribenuron methyl.

        [[Page 56716]]

      2. Chronic risk. Using the exposure assumptions described in this unit for chronic exposure, EPA has concluded that exposure to tribenuron methyl from food will utilize

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT